US biotech giant Pfizer will ramp up manufacturing of antimicrobials and precision medicines from its Melbourne site to combat the rising threat of superbugs after tipping $150 million into production facilities, robotics and artificial intelligence. The investment milestone was announced on Tuesday at the site in east Melbourne, with Industry and Science minister Ed Husic…

The post Pfizer’s $150m Melbourne upgrade to manufacture superbug defence appeared first on InnovationAus.com.

This post was originally published on InnovationAus.com.